NCT00093951

Data

{
  "briefSummary": "The purpose of this trial is to determine the effect of a new drug, SGS742, on memory and cognition in patients with mild to moderate Alzheimer's disease.",
  "completionDate": "2007-09",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 280,
  "enrollmentType": null,
  "nctId": "NCT00093951",
  "phase": "PHASE2",
  "sponsorId": "saegis-pharmaceuticals",
  "startDate": "2004-04",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase II Study of the Efficacy and Safety of SGS742 in Subjects With Mild to Moderate Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00093951"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version